XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
3.040
+0.060 (2.01%)
At close: May 16, 2025, 4:00 PM
3.100
+0.060 (1.97%)
After-hours: May 16, 2025, 4:28 PM EDT
XBiotech Market Cap
XBiotech has a market cap or net worth of $92.68 million as of May 16, 2025. Its market cap has decreased by -62.70% in one year.
Market Cap
92.68M
Enterprise Value
-63.21M
1-Year Change
-62.70%
Ranking
Category
Stock Price
$3.04
Market Cap Chart
Since April 15, 2015, XBiotech's market cap has decreased from $737.40M to $92.68M, a decrease of -87.43%. That is a compound annual growth rate of -18.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 16, 2025 | 92.70M | -23.01% |
| Dec 31, 2024 | 120.40M | -1.07% |
| Dec 29, 2023 | 121.70M | 13.95% |
| Dec 30, 2022 | 106.80M | -68.43% |
| Dec 31, 2021 | 338.30M | -26.12% |
| Dec 31, 2020 | 457.90M | -40.29% |
| Dec 31, 2019 | 766.90M | 321.37% |
| Dec 31, 2018 | 182.00M | 30.37% |
| Dec 29, 2017 | 139.60M | -57.50% |
| Dec 30, 2016 | 328.50M | -6.09% |
| Dec 31, 2015 | 349.80M | -52.56% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 658.30B |
| Johnson & Johnson | 359.97B |
| AbbVie | 320.92B |
| Novo Nordisk | 289.00B |
| UnitedHealth Group | 248.87B |
| Abbott Laboratories | 232.01B |
| Novartis AG | 211.47B |
| AstraZeneca | 208.86B |